Results 51 to 60 of about 31,799 (185)

Malignant argentaffinoma and the carcinoid syndrome.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2000
No Abstract.
Krikler, Dennis M., Lackner, Henriette, Seally, Rossall   +2 more
openaire   +2 more sources

Octreotide Acetate Long-Acting Formulation Versus Open-Label Subcutaneous Octreotide Acetate in Malignant Carcinoid Syndrome

, 1999
PURPOSE: Subcutaneous (SC) octreotide acetate effectively relieves the diarrhea and flushing associated with carcinoid syndrome but requires long-term multiple injections daily. A microencapsulated long-acting formulation (LAR) of octreotide acetate has
Ronald Bukowski, Jaffer Ajani, Joseph Rubin, William Schirmer, Rodney Pommier, Lowell Anthony, Alan P. Venook, Leonard Saltz, Paresh Dandona   +8 more
core   +1 more source

Characterization of the Oral Bacteria in Patients With Neuroendocrine Tumors of the Pancreas

Cancer Medicine, Volume 15, Issue 4, April 2026.
ABSTRACT The primary objective of this study was to investigate dysbiosis in the oral microbiota of patients with pancreatic neuroendocrine tumors (pNETs) and to identify potential biomarkers for clinical diagnosis and prognostic evaluation of pNETs. Healthy controls and pNETs patients were recruited from our hospital.
Jiayue Yao, Chunming Fei, Han Wu, Zhenyu Zhang, Zongdan Jiang   +4 more
wiley   +1 more source

Five Advances in the Last 50 Years That Have Impacted Endocrine Surgery

World Journal of Surgery, EarlyView.
Matilda Anneback, Priya H. Dedhia, Aimee Di Marco, Els Nieveen van Dijkum, Julie A. Miller, Janice L. Pasieka   +5 more
wiley   +1 more source

Enhancing Diagnostic Pathways for Bronchopulmonary Neuroendocrine Tumors: Assessment of the South Wales Neuroendocrine Tumor Service Transformation

Thoracic Cancer, Volume 17, Issue 8, April 2026.
Implementation of a dedicated neuroendocrine cancer service in South Wales significantly shortened diagnostic and treatment timelines for bronchopulmonary NETs, demonstrating the benefits of coordinated specialist input. ABSTRACT Background Bronchopulmonary neuroendocrine tumors (bpNETs) are uncommon lung neoplasms posing significant diagnostic and ...
Arouba Imtiaz, Oliver Burbidge, Mat Jones, Robin Ghosal, Janardhan Navaratnam, Craig Dyer, Helen E. Davies, Mohid S. Khan   +7 more
wiley   +1 more source

Neuroendocrine tumors: Laboratory diagnosis [PDF]

Journal of Medical Biochemistry, 2010
Neuroendocrine tumors (NETs) are a heterogeneous group of neoplasms originating from endocrine cells, which are characterized by the presence of secretory granules as well as the ability to produce biogenic amines and polypeptide hormones.
Tzontcheva Anna
doaj  

Above-label Doses of Octreotide-LAR in Patients with Metastatic Small-intestinal Carcinoid Tumors.

, 2012
Background: Octreotide LAR is indicated for treatment of the malignant carcinoid syndrome, and has been studied at doses of 10-30mg intramuscularly every 4 weeks.
Strosberg, Jonathan R., Kvols, Larry, Weber, Jill M., Feldman, Max   +3 more
core   +1 more source

European Society of Neuroendocrine Tumors (ENETS) 2025 guidance paper for lung and thymic carcinoids

Journal of Neuroendocrinology, Volume 38, Issue 4, April 2026.
Abstract This ENETS guidance paper, developed by a multidisciplinary working group, provides up‐to‐date and practical advice on the diagnosis and management of lung and thymic carcinoids, based on recent developments and study results. These recommendations aim to provide practical recommendations for the diagnosis, treatment and follow‐up of these ...
Eric Baudin, Alice Durand, Wieneke Buikhuisen, Jaume Capdevila, Martyn Caplin, Christophe M. Deroose, Clarisse Dromain, Antongiulio Faggiano, Pier Luigi Filosso, Gregory Kaltsas, Marco Volante, Thomas Walter, Rocio Garcia‐Carbonero   +12 more
wiley   +1 more source

Cutaneous paraneoplastic syndromes. Dermatological manifestations associated with malignancies

Journal of Education, Health and Sport
Introduction and purpose: Paraneoplastic syndromes (PS) are conditions associated with malignant tumours whose mechanism of onset is not fully understood.
Paulina Polańska, Marta Gruszka, Martyna Zakrocka, Maria Kubicka   +3 more
doaj   +1 more source

Incidence patterns and temporal trends of childhood cancer in Germany, 1980–2019: Forty years of childhood cancer registration in Germany

International Journal of Cancer, Volume 158, Issue 6, Page 1541-1554, 15 March 2026.
What's new? Childhood cancer ranks among the leading causes of disease‐related deaths in children in high‐income countries. Established risk factors, however, account for only a small proportion of incident childhood cancers. In this report, the authors present the first long‐term assessment of temporal trends in childhood cancer incidence rates in ...
Friederike Erdmann, Maike Wellbrock, Claudia Trübenbach, Desiree Grabow, Martin Schrappe, Peter Kaatsch, Claudia Spix, Joachim Schüz, Cécile M. Ronckers   +8 more
wiley   +1 more source